OpenAI's MedChemBench Scores AI on Retrospective Drug Chemistry Tasks
OpenAI has released MedChemBench, a benchmark that tests AI models on medicinal-chemistry reasoning such as interpreting molecular structures, weighing experimental data, and choosing compounds for further testing. The release reports that GPT-6.2 Astra scored 84.5% of available credit at the xhigh reasoning setting, with other models trailing behind. The benchmark comprises 99 problems drawn from 117 published papers and patents, and it reconstructs past decision points without covering clinical development or new laboratory experiments. Scores are aggregated across differently graded task types, including structure matching, numerical prediction, rankings, and a model-judged rationale component, which can obscure weaknesses in specific areas. Analysts caution that the score measures performance on a retrospective test and should not be read as a probability of successful drug discovery.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.
Discussion (0)
Log in to join the discussion and vote.
Log in